Below are the most recent publications written about "Positron-Emission Tomography" by people in Profiles.
-
Corazzolla G, Treaba CA, Mohammadian M, Brusaferri L, Barletta VT, Z?rcher NR, Hooker JM, Sloane JA, Klawiter EC, Bomprezzi R, Rocca MA, Filippi M, Loggia ML, Mainero C. Evidence of skull bone translocator protein overexpression linked to multiple sclerosis progression. Brain. 2026 Jun 03; 149(6):2032-2045.
-
Koops EA, Giudicessi A, Baena A, Martinez L, Bonillas-Felix N, Medrano R, Dutta J, Gonzalez I, Alvarez S, Aguillon D, Quiroz YT, Jacobs HIL. Vulnerability of the locus coeruleus-entorhinal cortex white matter tract in autosomal dominant Alzheimer's disease. Alzheimers Dement. 2026 Jun; 22(6):e71587.
-
Robinson TL, Montenegro GDC, Fu JF, Pintucci EN, Properzi MJ, Penney DL, Davis R, Sperling RA, Johnson KA, Amariglio RE, Rentz DM. Digital maze test reveals cognitive performance patterns associated with amyloid-? and tau. Neuropsychology. 2026 Jul; 40(5):465-475.
-
Xia QD, Xu MY, Zhu XH, Yang J, Wang SG. PSMA PET/MRI-US Fusion-Guided Irreversible Electroporation for Focal Therapy of Prostate Cancer. Clin Nucl Med. 2026 Aug 01; 51(8):661-663.
-
Petersen KK, Mil?-Alom? M, Li Y, Du L, Xiong C, Tosun D, Saef B, Saad ZS, Du-Cuny L, Coomaraswamy J, Mordashova Y, Rubel CE, Meyers EA, Shaw LM, Dage JL, Ashton NJ, Zetterberg H, Ferber K, Triana-Baltzer G, Baratta M, Rosenbaugh EG, Cruchaga C, McDade E, Holtzman DM, Morris JC, Sabandal JM, Bateman RJ, Bannon AW, Potter WZ, Schindler SE. Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocks. Nat Med. 2026 Mar; 32(3):1085-1094.
-
C?novas R, Cox T, Dor? V, Bourgeat P, Fripp J, Feizpour A, Shishegar R, Fowler CJ, Laws SM, Porter T, Rainey-Smith S, Shaw LM, Bateman RJ, Li Y, Vitaliy O, Weiner MW, Morris JC, Benzinger TLS, Schindler SE, Nakamura A, Iwatsubo T, Ikeuchi T, Kato T, Maruff P, Sohrabi HR, Rowe CC, Martins RN, Masters CL, Doecke JD. When Does Alzheimer's Disease Start? Plasma A?42/40 Assays Show Steep Changes at A?-PET Centiloid 15, Mean Age of 66?Years. Ann Neurol. 2026 May; 99(5):1327-1342.
-
Basile GA, Ielo A, Bonanno L, Cerasa A, Santoro G, Milardi D, Anastasi GP, Torre A, Baldari S, Laudicella R, Gaeta M, Quartu M, Serra MP, Trucas M, Quartarone A, Saranathan M, Cacciola A. Shared functional organization between pulvinar-cortical and cortico-cortical connectivity and its structural and molecular imaging correlates. Elife. 2025 Oct 13; 13.
-
Cousins KAQ, Korecka M, Wan Y, Vulaj A, Brown C, Tropea TF, Lee EB, Tosun D, Landau SM, Okonkwo OC, Mindt MR, Weiner MW, Irwin DJ, Wolk DA, Shaw LM. Comparison of plasma p-tau217/A?42, p-tau217, and A?42/A?40 biomarkers by race to detect Alzheimer's disease. Alzheimers Dement. 2025 Aug; 21(8):e70469.
-
Azimi MS, Felfelian V, Zeraatkar N, Dadgar H, Arabi H, Zaidi H. Deep supervised transformer-based noise-aware network for low-dose PET denoising across varying count levels. Comput Biol Med. 2025 Sep; 196(Pt A):110733.
-
Bu XL, Zhu W, Wang QH, Liu ZT, Bao YY, Bai YD, Li JH, Liu ZH, Zhao JL, Xiang Y, Jin WS, Wang J, Lei X, Wang YJ. Association between self-reported multimorbidity and longitudinal brain A? deposition in Alzheimer's disease. Nat Commun. 2025 Jul 01; 16(1):5905.